
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
